Evidence map›Paper›PMID 32228654›Full record

ReviewRadiation oncology (London, England)2020

Recent advances in radiotherapy of breast cancer.

Jan Haussmann, Stefanie Corradini, Carolin Nestle-Kraemling, Edwin Bölke, Freddy Joel Djiepmo Njanang, Bálint Tamaskovics, Klaus Orth, Eugen Ruckhaeberle, Tanja Fehm, Svjetlana Mohrmann and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Radiation oncology (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 3 syntheses or guidelines pooled it, 178 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Integrated approaches to sensitizing melanoma to radiotherapy.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jan HaussmannMedical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.
Stefanie CorradiniDepartment of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Carolin Nestle-KraemlingDepartment of Gynecologic and Obstetrics, Evanglisches Krankenhaus Dusseldorf, Dusseldorf, Germany.
Edwin BölkeMedical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany. boelke@med.uni-duesseldorf.de.
Freddy Joel Djiepmo NjanangMedical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.
Bálint TamaskovicsMedical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.
Klaus OrthMedical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.
Eugen RuckhaeberleDepartment of Gynecology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
Tanja FehmDepartment of Gynecology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
Svjetlana MohrmannDepartment of Gynecology, Heinrich Heine University Düsseldorf, Dusseldorf, Germany.
Ioannis SimiantonakisMedical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.
Wilfried BudachMedical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.
Christiane MatuschekMedical Faculty, Department of Radiation Oncology, Heinrich Heine University, Dusseldorf, Germany.
Heinrich Heine University Düsseldorf · DEEvangelisches Krankenhaus Düsseldorf · DELMU Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation therapy is an integral part of the multidisciplinary management of breast cancer. Regional lymph node irradiation in younger trials seems to provide superior target coverage as well as a reduction in long-term toxicity resulting in a small benefit in the overall survival rate. For partial breast irradiation there are now two large trials available which support the role of partial breast irradiation in low risk breast cancer patients. Multiple randomized trials have established that a sequentially applied dose to the tumor bed improves local control with the cost of worse cosmetic results.

Indexed as

Breast NeoplasmsClinical Trials as TopicFemaleHumansRadiotherapy, Adjuvant

Identifiers

PMID32228654
PMCPMC7106718
OpenAlexW3013063091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.